drugset / Trial / NCT03993704
Multiple Ascending Oral Dose 14-Day Trial of LHF-535 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of a daily oral dose of LHF-535 administered for 14 days to healthy participants.
Timeline
- Start
- 2019-09-16
- Primary completion
- 2020-01-09
- Completion
- 2020-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LHF-535 | Small molecule | 450 mg | Oral |
| Subject | LHF-535 | Small molecule | 1125 mg | Oral |
| Subject | LHF-535 | Small molecule | 2250 mg | Oral |
Indications
No indication recorded.